SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?


To: john douglas who wrote (572)12/15/1997 4:27:00 PM
From: Naggrachi  Read Replies (1) | Respond to of 2068
 
Never mind what DLJ saiz, starting tomorrow, CNBC, the most accurate financail media next to IBD (not) will have a series of special reports on HMO's. From the look of the sound bites, OXHP could go as low as $13 when all is said and done. "you get what you get, not what you want!!" said a cute (I think) blonde consumer.

Credit CNBC for bringing financial reporting to the same level as those tabloid TV shows. All that glitz and graphics and sound bites no longer than 5 seconds, the attention span must be really getting short, or so they think.

Zead

P.s. Haven't pulled the triger yet.



To: john douglas who wrote (572)12/15/1997 11:02:00 PM
From: Louis Cristiano  Read Replies (1) | Respond to of 2068
 
John, the comment regarding DLJ was reported on CNBC thursday morning by Mark Haynes and reiterated by Joe (forgot his last name).

P.S. I'd like to add my own comments about all this negative news surrounding OXHP.

In less than a month, all this will be ancient history.

In less than three months, all will be forgotten.

In less than six months, the brokerage houses, after having filled their coffers with OXHP stock, will begin promoting it as undervalued.

In less than a year OXHP will be a growth stock again that everyone will be chasing.

The healing has started. Believe it.